Literature DB >> 10701798

Polymicrobial cholangitis and liver abscess in a patient with the acquired immunodeficiency syndrome.

O A Alvarez1, F Vanegas, G L Maze, G W Gross, M Lee.   

Abstract

Cholangitis/cholangiopathy associated with the human immunodeficiency virus (HIV) infection is characterized by chronic abdominal pain, low-grade fever, cholestasis, and sometimes areas of focal or diffuse dilatation of the bile ducts that may be apparent on noninvasive imaging studies. Although the etiology of this biliary disease may be multifactorial, it appears to be the result of immunosuppression and/or secondary opportunistic infections rather than a direct cytopathic effect of HIV itself. Various opportunistic pathogens, including cytomegalovirus, Cryptosporidium, Campylobacter fetus, and Candida albicans, have been implicated as causes of HIV-associated cholangitis. We report an unusual case of polymicrobial cholangitis and liver abscess in a patient with HIV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701798

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Biliary sepsis in a patient on anti-TNFalpha therapy.

Authors:  D A McNamara; D Molony; J Mulsow; P R O'Connell
Journal:  Ir J Med Sci       Date:  2001 Jul-Sep       Impact factor: 1.568

Review 2.  Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies.

Authors:  Marco Fiore; Marco Cascella; Sabrina Bimonte; Alberto Enrico Maraolo; Ivan Gentile; Vincenzo Schiavone; Maria Caterina Pace
Journal:  Infect Drug Resist       Date:  2018-01-29       Impact factor: 4.003

Review 3.  Severe Acute Cholangitis and Bacteremia Due to Campylobacter jejuni: A Case Report and Review of the Literature.

Authors:  Kento Shionoya; Ryosuke Tonozuka; Takao Itoi; Atsushi Sofuni; Takayoshi Tsuchiya; Kentaro Ishii; Reina Tanaka; Shuntaro Mukai; Kazumasa Nagai; Kenjiro Yamamoto; Itaru Nakamura
Journal:  Intern Med       Date:  2021-05-22       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.